These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 3114964
1. [Long-term intravesical treatment with adriamycin in chemoprevention of recurrence of transurethrally resected urinary bladder cancers]. Flamm J, Grof F. Wien Med Wochenschr; 1987 Jul 15; 137(13):315-7. PubMed ID: 3114964 [Abstract] [Full Text] [Related]
2. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder. Koga H, Kuroiwa K, Yamaguchi A, Osada Y, Tsuneyoshi M, Naito S. J Urol; 2004 Jan 15; 171(1):153-7. PubMed ID: 14665865 [Abstract] [Full Text] [Related]
3. [Prevention of recurrence in urinary bladder tumors by intravesical instillation treatment with adriamycin]. Flamm J, Grof F. Urologe A; 1985 Jan 15; 24(1):31-5. PubMed ID: 4039083 [Abstract] [Full Text] [Related]
4. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer]. Flamm J, Kühnel W, Dona S. Urologe A; 1989 Mar 15; 28(2):99-102. PubMed ID: 2655259 [Abstract] [Full Text] [Related]
5. [Results and long-term course of superficial bladder carcinomas treated with local adriamycin. Apropos of 69 cases]. Iborra I, Mazcuñán F, Monros JL, Ricos JV, Solsona E. Arch Esp Urol; 1987 Sep 15; 40(7):455-60. PubMed ID: 3688987 [No Abstract] [Full Text] [Related]
6. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer. Librenjak D, Situm M, Eterovic D, Dogas Z, Gotovac J. Croat Med J; 2003 Apr 15; 44(2):187-92. PubMed ID: 12698510 [Abstract] [Full Text] [Related]
8. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT, Yildirim U, Zorlu F, Ozen H. J Urol; 2006 May 15; 175(5):1641-4. PubMed ID: 16600720 [Abstract] [Full Text] [Related]
11. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, BCG Tokyo 172 Strain Study Group. Urology; 2006 Mar 15; 67(3):545-9. PubMed ID: 16527576 [Abstract] [Full Text] [Related]
13. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor]. Kuroda K, Ishii N, Fukasawa K, Shirai M, Tajima M, Matsushima M, Miura K, Takanami M, Matsuhashi M, Kuwabara T, Matsumoto H, Sugita M. Hinyokika Kiyo; 1998 Aug 15; 44(8):547-52. PubMed ID: 9783189 [Abstract] [Full Text] [Related]
14. Early adjuvant adriamycin in superficial bladder carcinoma. Schulman CC, Denis LJ, Costerlinck W, De Sy W, Chantrie M, Bouffioux C, Van Cangh PJ, Van Erps P, De Sloover C. Prog Clin Biol Res; 1984 Aug 15; 162B():151-62. PubMed ID: 6390444 [Abstract] [Full Text] [Related]
16. [A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer]. Masuda F, Mori Y, Torii S, Kawashima Y, Kobari T, Hosobe T. Gan To Kagaku Ryoho; 1992 Apr 15; 19(4):505-8. PubMed ID: 1558400 [Abstract] [Full Text] [Related]
17. Treatment of bladder cancer with intravesical instillation of adriamycin. Pavone-Macaluso M, Ingargiola GB, Tripi M, Lamartina M. Prog Clin Biol Res; 1984 Apr 15; 162B():181-91. PubMed ID: 6390445 [Abstract] [Full Text] [Related]